Plus Therapeutics | CYTX - Sales Revenues

Stock Price
0.30
Daily Change
-0.01 -2.88%
Monthly
15.47%
Yearly
-79.16%
Q1 Forecast
0.29

Plus Therapeutics reported $1.31M in Sales Revenues for its fiscal quarter ending in December of 2023.





Sales Change Date
Baxter International USD 2.97B 130M Dec/2025
Cerus USD 50.81M 4.79M Dec/2024
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Infinity Pharmaceuticals USD 583K 148K Jun/2023
Northwest Biotherapeutics USD 445K 39K Dec/2023
Plus Therapeutics USD 1.31M 73K Dec/2023
Sanofi EUR 11.3B 1.13B Dec/2025
Starpharma Holdings AUD 10.83M 9.12M Dec/2025
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025